Indian-American scientist opens historic science court on Pfizer vaccine

Indian American scientist Dr Prabhakara Atreya opened America's historic "science court" on Thursday as a high-powered team of US regulators and independent experts who make up the Vaccines and Related Biological Products Advisory Committee (VRBPAC) begin an all-day debate on emergency use authorisation for Pfizer's COVID-19 vaccine

Dec 11, 2020
Image
A

Indian American scientist Dr Prabhakara Atreya opened America's historic "science court" on Thursday as a high-powered team of US regulators and independent experts who make up the Vaccines and Related Biological Products Advisory Committee (VRBPAC) begin an all-day debate on emergency use authorisation for Pfizer's COVID-19 vaccine. Atreya is the Acting Designated Federal Officer of VRBPAC which is at the heart of this blowout moment which marks a crucial turn in America's catastrophic experience with the coronavirus.

A TEN-year veteran at the US Food and Drug Administration which she joined in 2010, Atreya, prior to this appointment, worked at the National Institutes of Health, leading the Office of Scientific Review. She has a PhD in biochemistry, biophysics and molecular biology from the Memorial University of Newfoundland, in Canada.

Atreya joins a long list of Indian scientists and physicians who have come to represent the face of Indian Americans leading either policy or practitioner roles in the middle of a raging pandemic. Atreya was the first speaker at the Thursday meeting and kicked off the debate by introducing members of the VRBPAC.

The US FDA is expected to go along with the advice of the VRBPAC and there is no deadline for a decision.

"We want people to see this discussion, to see the issues that are brought up, and have a vigorous discussion of the data elements by the outside experts," FDA Commissioner Stephen Hahn said in an interview.

When vaccinations do begin, health care workers and nursing home residents will be first in line.

(IANS)

Tweets about SAMonitor
SAM Facebook

DMM Thank you

SPS-NBN

News Behind the News Special Studies

Newsletter Subscription

The subscriber's email address.
Stay informed - subscribe to our newsletter.